articleThe LancetJun 12, 2024Closed access

Doublet chemotherapy, triplet chemotherapy, or doublet chemotherapy combined with radiotherapy as neoadjuvant treatment for locally advanced oesophageal cancer (JCOG1109 NExT): a randomised, controlled, open-label, phase 3 trial

National Cancer Center · National Cancer Center Hospital East · +15 more institutions

PubMed
Indexed incrossrefpubmed

Abstract

No abstract available for this paper.

Citation impact

219
total citations
FWCI
111.24
Percentile
100%
References
34
Citations per year

Authors

65

Topics & keywords

Keywords
  • Chemotherapy
  • Medicine
  • Oncology
  • Radiation therapy
  • Open label
  • Internal medicine
  • Randomized controlled trial
UN Sustainable Development Goals
  • Good health and well-being
No related works found for this paper.